These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8534745)

  • 21. Relationship of peritoneal transport rate and dialysis adequacy with inflammation in peritoneal dialysis patients.
    Fein PA; Fazil I; Rafiq MA; Schloth T; Matza B; Chattopadhyay J; Avram MM
    Adv Perit Dial; 2006; 22():2-6. PubMed ID: 16983929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nutritional parameters in diabetic patients on CAPD.
    Scanziani R; Dozio B; Bonforte G; Surian M
    Adv Perit Dial; 1996; 12():280-3. PubMed ID: 8865919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adequacy of peritoneal dialysis: does kt/v have the same predictive value as in HD? A multicenter study.
    De Alvaro F; Bajo MA; Alvarez-Ude F; Vigil A; Molina A; Coronel F; Selgas R
    Adv Perit Dial; 1992; 8():93-7. PubMed ID: 1361862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study.
    Delaney MP; Stevens PE; Al Hasani M; Stowe HJ; Judge C; Lamb EJ
    Am J Kidney Dis; 2008 Feb; 51(2):278-84. PubMed ID: 18215705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of CAPD prescription.
    Acchiardo SR; Kraus AP; Kaufman PA; LaHatte G; Adkins D; Moore LW
    Adv Perit Dial; 1991; 7():47-50. PubMed ID: 1680455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-sectional analysis of erythropoietin use in CPD: its relation to azotemic index clearances.
    Fox L; Tzamaloukas AH; Antoniou S; Katsoudas S; Tzouganatou A; Chisam G; Goldman RS; Kakavas J; Dimitriadis A; Nicolopoulou N
    Adv Perit Dial; 1995; 11():243-6. PubMed ID: 8534715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of the dialysis adequacy and transport test in peritoneal dialysis.
    Seo JJ; Kim YL; Park SH; Kim CD; Kim JC; Jang MH; Choi HJ
    Adv Perit Dial; 2005; 21():25-30. PubMed ID: 16686280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating the daily dialysate drain volume required in CAPD for a target peritoneal creatinine clearance by body water and peritoneal transport characteristics.
    Rao P; Tzamaloukas AH; Murata GH; Piraino B; Malhotra D; Bernardini J; Oreopoulos DG
    Adv Perit Dial; 1997; 13():33-7. PubMed ID: 9360647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High flux peritoneal membrane is a risk factor in survival of CAPD treatment.
    Wu CH; Huang CC; Huang JY; Wu MS; Leu ML
    Adv Perit Dial; 1996; 12():105-9. PubMed ID: 8865883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of increasing exchange volume and frequency on peritoneal dialysis adequacy.
    Gao H; Lew SQ; Bosch JP
    Clin Nephrol; 1998 Dec; 50(6):375-80. PubMed ID: 9877111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dialysis dose and nutrition in Japanese peritoneal dialysis patients.
    Ishizaki M; Yamashita AC; Kawanishi H; Nakamoto M; Hamada H
    Adv Perit Dial; 2004; 20():141-3. PubMed ID: 15384815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous ambulatory peritoneal dialysis with a high flux membrane.
    Nolph KD; Moore HL; Prowant B; Twardowski ZJ; Khanna R; Gamboa S; Keshaviah P
    ASAIO J; 1993; 39(4):904-9. PubMed ID: 8123925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years.
    Faller B; Lameire N
    Nephrol Dial Transplant; 1994; 9(3):280-6. PubMed ID: 8052436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of increasing exchange volume or frequency on CAPD efficiency.
    Johnston JR; Bernardini J; Holley J; Piraino B
    Adv Perit Dial; 1995; 11():97-100. PubMed ID: 8534748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Peritoneal equilibration test and its operation on CAPD patients].
    Wang HJ; Wang CF
    Zhonghua Hu Li Za Zhi; 1997 Feb; 32(2):63-5. PubMed ID: 9369554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limitations of the peritoneal equilibration test in prescribing and monitoring dialysis therapy.
    Harty JC; Goldsmith DJ; Boulton H; Heelis N; Uttley L; Morris J; Venning MC; Gokal R
    Nephrol Dial Transplant; 1995; 10(2):252-7. PubMed ID: 7753460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adequacy and nutrition in pediatric peritoneal dialysis.
    Cano FJ; Marín VS; Azocar MA; Delucchi MA; Rodriguez EE; Diaz ED; Villegas RC
    Adv Perit Dial; 2003; 19():273-8. PubMed ID: 14763078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of normalized protein catabolic rate to weekly creatinine clearance and KT/V in patients on peritoneal dialysis.
    Lutes R; Holley JL; Perlmutter J; Piraino B
    Adv Perit Dial; 1993; 9():97-100. PubMed ID: 8105973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re-evaluation of adequate dose in Japanese peritoneal dialysis patients.
    Yamashita AC; Ishizaki M; Nakamoto M; Kawanishi H; Hamada H
    Adv Perit Dial; 2003; 19():103-5. PubMed ID: 14763043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.